News
Press Releases
Pr
Press Release
Seqens confirms the acquisition of CELLforCURE
SEQENS confirms the acquisition of the CELLforCURE site at Les Ulis (91) from NOVARTIS as of December 1st, 2023.
Events and more
01
May 13-17, / New Orleans, LA
//Meet us booth #1047//
The mission of ASGCT is to advance knowledge, awareness, and education leading to the discovery and clinical application of genetic and cellular therapies to alleviate human disease.
02
September 23-26 / Boston, MA
Come and meet us
03
October 6-8 / Phoenix, AZ
Come and meet us
04
November 11-12 / London, UK
//Meet us booth #44//
Follow our presentation, November 12 at 11.15 AM
Track 2: Strategies for Cell Therapy Manufacturing
